Parameter | Number of patients (%) |
---|---|
Tumour size | Â |
   T1 | 118 (65.2) |
   T2 | 54 (29.8) |
   T3/4 | 9 (5.0) |
Age (years) | Â |
   <40 | 14 (7.7) |
   40–55 | 46 (25.4) |
   >55 | 121 (66.9) |
Histopathological grading | Â |
   G1 | 5 (2.8) |
   G2 | 105 (58) |
   G3 | 71 (39.2) |
ER status | Â |
   ER negative | 64 (35.4) |
   ER positive | 115 (63.5) |
   Unknown | 2 (1.1) |
PR status | Â |
   PR negative | 66 (36.5) |
   PR positive | 112 (61.9) |
   Unknown | 3 (1.7) |
Oncogenes | Â |
   C-myc nonamplified | 142 (78.5) |
   C-myc amplified | 39 (21.5) |
HER-2/neu nonamplified | 126 (69.6) |
HER-2/neu amplified | 55 (30.4) |
   C-myc and HER-2/neu coamplified | 22 (12.2) |